Operative mortalities were "acceptable", and "good palliation" was reported among those who underwent resection but were not cured.
Those of us who went to Amsterdam to the Second Congress of the World Association of Hepatic, Pancreatic and Biliary Surgeons will have been impressed by many things-the superb organisation, the standard of the presentations, the high level of the discussions, the clear confirmation that our surgical speciality really exists. Those with an interest in bile duct cancer will have learnt much, but may have come away with a feeling of vague disquiet.
Certain messages were very clear. High bile duct cancer is fairly common in some parts of the world. Surgeons should adopt an "aggressive" approach to its treatment and the word "aggressive" seemed to mean different things to different surgeons. At all events, resection of the tumour, with or without hepatic resection, emerged as the surgical ideal. Resection rates varied widely and without explanation. Launois reported a 50% resection rate, van der Heyde 16%. There seemed to be few cures to report, but survival times were felt to be better among those undergoing resection. Operative mortalities were "acceptable", and "good palliation" was reported among those who underwent resection but were not cured. 
